ArticleFrontiers in immunology2026

Alpha-galactosylceramide as mRNA vaccine adjuvant modulates cellular immunity against tuberculosis and contributes to antigen-specific lung-associated T cells with a TRM-associated phenotype following prime-pull strategy.

Ilke Aernout et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.